514. Oncology: Evidence-Based

You are here: Home / 514. Oncology: Evidence-Based

514. Oncology: Evidence-Based

 

 

CATEGORY: Medical & Medicine – 500 Courses

COURSE NUMBER: 514

FEES: 555/- INR only

CERTIFICATE VALIDITY: Lifetime

CERTIFICATES DELIVERY: In 48 hours

BOOKS/ MANUALS: Pages

Syllabus

Foreword by Gabriel N. Hortobagyi . . . . . . . . . . . . . . . . vii
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Section One Principles of Oncology
1 Evidence-Based Approach to Oncology . . . . . . . . . . . . . . . . . . . 3
Emily DeVoto and Barnett S. Kramer
2 Principles of Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Grace K. Dy and Alex A. Adjei
3 Principles of Radiation Oncology . . . . . . . . . . . . . . . . . . . . . . . 41
Timothy J. Kinsella, Jason Sohn, and Barry Wessels
4 Principles of Surgical Therapy in Oncology . . . . . . . . . . . . . . . 58
Michael S. Sabel, Kathleen M. Diehl, and Alfred E. Chang
5 Principles of Targeted and Biological Therapies . . . . . . . . . . . . 73
Stephen R.D. Johnston, Sue Chua, and Charles Swanton
6 Biologic Principles of Hematopoietic Stem
Cell Transplantation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Robert J. Soiffer
7 Evaluation of Tumor Markers: An Evidence-Based Guide for
Determination of Clinical Utility . . . . . . . . . . . . . . . . . . . . . . 106
Daniel F. Hayes
8 Design and Analysis of Oncology Clinical Trials . . . . . . . . . . . 112
James J. Dignam, Theodore G. Karrison, and John Bryant
9 Ethics of Clinical Oncology Research . . . . . . . . . . . . . . . . . . . 127
Manish Agrawal, Lindsay A. Hampson, and Ezekiel J. Emanuel
10 Informatics Infrastructure for Evidence-Based
Cancer Medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
Jeffrey P. Bond and Scott D. Luria
11 Economics of Cancer Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
James Khatcheressian and Thomas J. Smith
12 Principles of Screening for Cancer . . . . . . . . . . . . . . . . . . . . . . 161
Russell Harris and Linda S. Kinsinger
13 Patient Decision Making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
Peter A. Ubel
14 Establishing an Interdisciplinary Oncology Team . . . . . . . . . . . 184
Nathan Levitan, Meri Armour, and Afshin Dowlati

15 Principles of Complementary and Alternative Medicine
for Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Andrew J. Vickers and Barrie Cassileth
Section Two Translational Basic Science
16 Fundamental Aspects of the Cell Cycle and
Signal Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
Jeffrey R. Skaar and James A. DeCaprio
17 Viral Carcinogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
Michele Carbone and Giuseppe Barbanti-Brodano
18 Environmental Carcinogenesis . . . . . . . . . . . . . . . . . . . . . . . . . 233
T. Sabo-Attwood, M. Ramos-Nino, and
Brooke T. Mossman
19 Cancer Metastasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
Kevin McDonnell and Anton Wellstein
20 Tumor Immunology and Immunotherapy . . . . . . . . . . . . . . . . 254
Jeffrey Weber, Sophie Dessureault, and Scott Antonia
21 Technologies in Molecular Biology:
Diagnostic Applications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
Timothy J. Triche
Section Three Cancer Prevention and Control
22 Cancer Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287
Melissa L. Bondy and Shine Chang
23 Evidence-Based Cancer Prevention Research:
A Multidisciplinary Perspective on Cancer
Prevention Trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
Stephen D. Hursting, Michele R. Forman, Asad Umar,
Nomeli P. Nunez, and J. Carl Barrett
24 Screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317
Stephen H. Taplin, Sarah Dash, Paula Zeller,
and Jane Zapka
25 Genetic Screening and Counseling for
High-Risk Populations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341
Mary B. Daly
26 Behavior Modification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 358
Christopher N. Sciamanna
Section Four Cancer Imaging
27 Central Nervous System Imaging . . . . . . . . . . . . . . . . . . . . . . 369
Dima A. Hammoud and Martin G. Pomper

28 Breast Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 381
Wendie A. Berg
29 Imaging of Thoracic Malignancies . . . . . . . . . . . . . . . . . . . . . . 392
Caroline Chiles and Suzanne L. Aquino
30 Imaging of Gastrointestinal Stromal Tumor . . . . . . . . . . . . . . . 413
Ihab R. Kamel and Elliot K. Fishman
31 Genitourinary Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 425
Satomi Kawamoto, Harpreet K. Pannu, David A. Bluemke,
and Elliot K. Fishman
32 Musculoskeletal Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 442
Leanne L. Seeger and Kambiz Motamedi
33 Positron Emission Tomography and Cancer . . . . . . . . . . . . . . . 449
Daniel N. Chatzifotiadis, Julia W. Buchanan,
and Richard L. Wahl

Section Five Solid Tumors
34 Central Nervous System Tumors . . . . . . . . . . . . . . . . . . . . . . . 487
Ravi D. Rao, Paul D. Brown, Caterina Giannini,
Cormac O. Maher, Fredric B. Meyer, Evanthia Galanis,
Brad J. Erickson, and Jan C. Buckner
35 Eye, Orbit, and Adnexal Structures . . . . . . . . . . . . . . . . . . . . . 506
Daniel M. Albert, Marni Feldmann, Heather Potter,
and Amit Kumar
36 Head and Neck Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 528
Ezra E.W. Cohen, Kerstin M. Stenson, Michael Milano,
and Everett E. Vokes
37 Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 545
Hak Choy, Harvey I. Pass, Rafael Rosell, and Anne Traynor
38 Therapy for Malignant Pleural Mesothelioma . . . . . . . . . . . . . 622
Harvey I. Pass, Nicholas Vogelzang, Steven Hahn,
and Michele Carbone
39 Mediastinum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 645
Alexander S. Krupnick and Joseph B. Shrager
40 Esophageal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 664
John D. Urschel
41 Stomach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 680
Scott A. Hundahl, John S. Macdonald, and
Stephen R. Smalley
42 Colon, Rectal, and Anal Cancer Management . . . . . . . . . . . . . 704
John M. Skibber and Cathy Eng

43 Adenocarcinoma and Other Small Intestinal Malignancies . . . 733
John H. Donohue
44 Cancer of the Liver and Bile Ducts . . . . . . . . . . . . . . . . . . . . . 745
Michael L. Kendrick, Annette Grambihler, Gregory J. Gores,
Steven Alberts, and David M. Nagorney
45 An Evidence-Based Approach to the Management of
Pancreatic Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 764
Dan Laheru
46 Renal Cell Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 782
Joseph I. Clark, Craig Hofmeister, Vicki Keedy, and
Jeffrey A. Sosman
47 Ureter, Bladder, Penis, and Urethra . . . . . . . . . . . . . . . . . . . . . 806
Cheryl T. Lee, Brent Hollenbeck, and David P. Wood, Jr.
48 Prostate Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 826
Richard Whittington and David J. Vaughn
49 Testis Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 844
Timothy Gilligan and Phillip W. Kantoff
50 Cervix, Vulva, and Vagina . . . . . . . . . . . . . . . . . . . . . . . . . . . . 874
Julian C. Schink
51 Gestational Trophoblastic Neoplasia . . . . . . . . . . . . . . . . . . . . 892
John R. Lurain
52 Ovarian Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 903
Yukio Sonoda and David Spriggs
53 Uterine Malignancies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 928
Gini F. Fleming, Anthony C. Montag, Arno J. Mundt,
and S.D. Yamada
54 Evidence-Based Management of Breast Cancer . . . . . . . . . . . . . 951
Lisa A. Newman and Daniel F. Hayes
55 Thyroid and Parathyroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 983
Gerard M. Doherty
56 Tumors of the Endocrine System . . . . . . . . . . . . . . . . . . . . . . . 1005
Jeffrey A. Norton
57 Sarcomas of Bone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1025
Randy N. Rosier and Susan V. Bukata
58 Soft Tissue Sarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1039
T. Christopher Windham and Vernon K. Sondak
59 Cutaneous Melanoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1073
Mark R. Albertini, B. Jack Longley, Paul M. Harari, and
Douglas Reintgen
60 Nonmelanoma Cutaneous Malignancies . . . . . . . . . . . . . . . . . 1093
Montgomery Gillard, Timothy S. Wang, and
Timothy M. Johnson

61 Cancer of Unknown Primary Site . . . . . . . . . . . . . . . . . . . . . . 1110
F. Anthony Greco and John D. Hainsworth
62 Solid Tumors of Childhood . . . . . . . . . . . . . . . . . . . . . . . . . . . 1124
Crawford J. Strunk and Sarah W. Alexander
Section Six Hematologic Malignancies
63 Acute Myeloid Leukemia and the
Myelodysplastic Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . 1151
Jonathan E. Kolitz
64 Acute Lymphoblastic Leukemia . . . . . . . . . . . . . . . . . . . . . . . . 1173
Olatoyosi M. Odenike, Laura C. Michaelis,
and Wendy Stock
65 Chronic Lymphocytic Leukemia and Related
Chronic Leukemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1201
Thomas S. Lin and John C. Byrd
66 Chronic Myeloid Leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . 1220
Meir Wetzler
67 An Evidence-Based Approach to the Management of
Hodgkin’s Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1231
Craig H. Moskowitz
68 The Non-Hodgkin’s Lymphomas . . . . . . . . . . . . . . . . . . . . . . . 1247
Andrew D. Zelenetz and Steven Horwitz
69 Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1276
Robert L. Schlossman

Section Seven Practice of Oncology
70 Superior Vena Cava Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . 1291
Michael S. Kent and Jeffrey L. Port
71 Central Nervous System Emergencies . . . . . . . . . . . . . . . . . . . 1299
Kevin P. McMullen, Edward G. Shaw, and Volker W. Stieber
72 Metabolic Emergencies in Oncology . . . . . . . . . . . . . . . . . . . . 1312
Daniel J. De Angelo
73 Surgical Emergencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1323
David A. August, Thomas Kearney, and Roderich E. Schwarz
74 Oral Complications of Cancer Therapy . . . . . . . . . . . . . . . . . . 1340
Mark S. Chambers and Adam S. Garden
75 Alopecia and Cutaneous Complications of Chemotherapy . . . . 1354
Faith M. Durden and Paradi Mirmirani

76 Infectious Complications of Cancer Therapy . . . . . . . . . . . . . . 1363
Safdar Nasia, Christopher J. Crnich, and Dennis G. Maki
77 Acute Toxicities of Therapy: Pulmonary Complications . . . . . 1401
Scott E. Evans and Andrew H. Limper
78 Cardiac Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1411
Maged I. Gharib and Alan K. Burnett
79 Neurologic Complications of Therapy . . . . . . . . . . . . . . . . . . . 1418
Kristin Bradley and H. Ian Robins
80 Acute Toxicities of Therapy: Urologic Complications . . . . . . . 1426
Sandy Srinivas
81 Issues in Vascular Access with Special Emphasis on the
Cancer Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1434
Paul F. Mansfield and David L. Smith
82 Management of Cancer Pain . . . . . . . . . . . . . . . . . . . . . . . . . . 1446
Donald P. Lawrence, Leonidas C. Goudas, Andrew J. Lipman,
Joseph Lau, Rina M. Bloch, and Daniel B. Carr
83 Nausea and Vomiting in the Cancer Patient . . . . . . . . . . . . . . 1473
Paula Gill, Axel Grothey, and Charles Loprinzi
84 Nutritional Support for the Cancer Patient . . . . . . . . . . . . . . . 1488
Lawrence E. Harrison
85 Paraneoplastic Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1506
Shirish M. Gadgeel and Antoinette J. Wozniak
86 Malignant Effusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1518
Shamus R. Carr and Joseph S. Friedberg
87 Evidence-Based Use of Hematopoietic Growth Factors
for Optimal Supportive Care of Patients with Cancer . . . . . . . 1526
George D. Demetri
88 Management of the Bone Marrow Transplant Patient . . . . . . . 1536
Daniel J. Weisdorf and Marcie Tomblyn
89 Management of Anxiety and Depression in Adult Cancer
Patients: Toward an Evidence-Based Approach . . . . . . . . . . . . . 1552
Paul B. Jacobsen, Kristine A. Donovan, Zoë N. Swaine,
and Iryna S. Watson
90 Reproductive Complications and Sexual Dysfunction in the
Cancer Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1580
Leslie R. Schover
91 The Care of the Terminal Patient . . . . . . . . . . . . . . . . . . . . . . 1601
Andrew Putnam

92 Metastatic Cancer to the Central Nervous System . . . . . . . . . 1612
Douglas B. Einstein
93 Metastatic Cancer to Lung . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1626
Jessica S. Donington
94 Surgical and Regional Therapy for Liver Metastases . . . . . . . . . 1636
Kenneth K. Tanabe and Sam S. Yoon
95 Metastatic Cancer to Bone . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1655
Patrick J. Getty, Jeffrey L. Nielsen, Thomas Huff,
Mark R. Robbin, and Beth A. Overmoyer
96 Cancer in the Immunosuppressed Patient . . . . . . . . . . . . . . . . 1680
Patrick Whelan and David T. Scadden
97 Cancer in the Older Population . . . . . . . . . . . . . . . . . . . . . . . . 1708
Karim S. Malek and Rebecca A. Silliman
98 Chemotherapy in Patients with Organ Dysfunction . . . . . . . . 1721
John L. Marshall, Jimmy Hwang, Shakun Malik,
and Asim Amin
99 Management of the Pregnant Cancer Patient . . . . . . . . . . . . . . 1738
Deepjot Singh and Paula Silverman

Section Eight Cancer Survivorship
100 Survivorship Research: Past, Present, and Future . . . . . . . . . . . 1753
Julia H. Rowland
101 Late Effects of Cancer Treatments . . . . . . . . . . . . . . . . . . . . . . 1768
Noreen M. Aziz
102 Medical and Psychosocial Issues in Childhood
Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1791
Smita Bhatia, Wendy Landier, Jacqueline Casillas,
and Lonnie Zeltzer
103 Medical and Psychosocial Issues in Hodgkin’s
Disease Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1804
Jon H. Loge and Stein Kaasa
104 Medical and Psychosocial Issues in Testicular
Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1815
Sophie D. Fosså, Lois B. Travis, and Alvin A. Dahl
105 Medical and Psychosocial Issues in Gynecologic
Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1828
Karen Basen-Engquist and Diane C. Bodurka
106 Medical, Psychosocial, and Health-Related Quality of Life
Issues in Breast Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . 1836
Julie Lemieux, Louise J. Bordeleau, and Pamela J. Goodwin

107 Medical and Psychosocial Issues in Prostate
Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1859
Tracey L. Krupski and Mark S. Litwin
108 Physical and Psychosocial Issues in Lung
Cancer Survivors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1871
Linda Sarna, Frederic W. Grannis, Jr., and Anne Coscarelli
109 Cancer Survivorship Issues in Colorectal Cancer . . . . . . . . . . . 1891
Clifford Y. Ko and Patricia A. Ganz
110 Medical and Psychosocial Issues in Transplant Survivors . . . . 1902
Karen L. Syrjala, Paul Martin, Joachim Deeg, and
Michael Boeckh
111 Second Malignancies After Radiation Treatment and
Chemotherapy for Primary Cancers . . . . . . . . . . . . . . . . . . . . . 1929
Lydia B. Zablotska, Matthew J. Matasar,
and Alfred I. Neugut
112 Psychosocial Rehabilitation in Cancer Care . . . . . . . . . . . . . . . 1942
Richard P. McQuellon and Suzanne C. Danhauer
113 Cancer Advocacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1955
Ellen L. Stovall
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1959

……………………………………………………………………………………………………………………………………………………………………………………………………………………

 

Medifit  Courses Demo Certificate 

48 hours delivery

| International acceptance | Medical based | Job oriented | Lifetime validity | Most economical |

 

555 INR Demo Certificate – 2 months duration

Demo Certificate – 6 months duration

48 hours delivery after fees payment

48 hours delivery after fees payment

 

Medifit 48 hours Delivery

  Get your Certificates delivered by online mode in 48 hours after Fees payment. We try to deliver certificates in 24 hours, but the committed delivery hours are 48. Its,

Pay Today &
get Tomorrow

procedure, only by Medifit.

LIFETIME VALIDITY

Medifit issues Lifetime validity certificates for all Online Courses provided. No need to renew the certificates every 2 or 3 years. All Courses Certificates of Medifit are having Lifetime Validity. No need to renew these certificates every 2 or 3 years.

 

What makes the certificates of Medifit to get it recognized Internationally?

Vast number of students applying for Job in international market of Fitness through Medifits Online Courses Certificates. And most importantly, the Medical standards maintained, helps to acquire jobs internationally. This gives very strong International acceptance to Certificates of Medifit Courses.

 

ABOUT MEDIFIT ACADEMY CERTIFICATION COURSE:

Medifit Education Online Academy is an innovative, digital and engaging education platform that delivers fast track accredited courses and skills development courses instantly online, with no time limits, enabling individuals to study anywhere and anytime. We are proud to offer international standard courses that have helped our students build their careers across the globe.

HOW DO MEDIFIT ONLINE CERTIFICATE COURSES HELP?

Short term Professional Courses International Standards courses Opens Global opportunities Career defining Courses Skill Development Programmes Knowledge in short span Learn at your own pace Certification of Completion Immediate Earning Opportunities Positive Social Impact Optimistic Psychological Benefits Improved Standard of Living Study from anywhere & anytime Very Economical Fees